Fig. 2From: Assessment of interactions of efavirenz solid drug nanoparticles with human immunological and haematological systemsImpact of sample materials on plasma coagulation times. Plasma coagulation times assessed for the three main coagulation pathways in healthy volunteer blood treated with efavirenz aqueous solution or efavirenz SDN. Data are shown as the mean ± standard deviationBack to article page